Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy on Hemodialysis-Reference-Cited by-同舟云学术

Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy on Hemodialysis

Published:2013-03-27 Issue:4 Volume:35 Page:244-249
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Takenaka Tsuneo,Okayama Mika,Kojima Eriko,Nodaira Yuka,Arai Jonde,Uchida Kosuke,Kikuta Tomohiro,Sueyoshi Keita,Hoshi Hitoshi,Watanabe Yusuke,Takane Hiroshi,Suzuki Hiromichi

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10641963.2013.780066

Reference26 articles.

1. Existence of Early-Onset NIDDM Japanese Demonstrating Severe Diabetic Complications

2. Tachycardia as a predictor of poor survival in chronic haemodialysis patients

3. Cardio-Ankle Vascular Index to Screen Cardiovascular Diseases in Patients with End-Stage Renal Diseases

4. Optimum Second Screening Point for Detection of Coronary Artery Disease in Hemodialysis Patients without Advanced Coronary Artery Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medications that cause weight gain and alternatives in Canada: a narrative review;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2018-08

2. Intradialysis Hypertension in End-Stage Renal Disease Patients;Hypertension;2015-09

3. Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis;The Open Cardiovascular Medicine Journal;2014-02-07